The protective effect of


Journal

Gut microbes
ISSN: 1949-0984
Titre abrégé: Gut Microbes
Pays: United States
ID NLM: 101495343

Informations de publication

Date de publication:
02 09 2020
Historique:
pubmed: 10 6 2020
medline: 29 6 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

Proton pump inhibitors (PPIs) can alleviate upper gastrointestinal injury but paradoxically exacerbate aspirin (ASA)-induced small intestine injury. In this study, our goal was to simulate this exacerbation by developing an appropriate animal model, which may help in establishing treatments.

Sections du résumé

BACKGROUND
Proton pump inhibitors (PPIs) can alleviate upper gastrointestinal injury but paradoxically exacerbate aspirin (ASA)-induced small intestine injury. In this study, our goal was to simulate this exacerbation by developing an appropriate animal model, which may help in establishing treatments.

Identifiants

pubmed: 32515658
doi: 10.1080/19490976.2020.1758290
pmc: PMC7527075
doi:

Substances chimiques

Cytokines 0
Dietary Sugars 0
Proton Pump Inhibitors 0
Omeprazole KG60484QX9
Aspirin R16CO5Y76E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1385-1404

Références

Gut Liver. 2016 Nov 15;10(6):896-901
pubmed: 27458177
Gastroenterology. 2000 Feb;118(2):337-45
pubmed: 10648462
Nature. 2004 Jul 8;430(6996):218-22
pubmed: 15241416
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Arch Surg. 1970 Oct;101(4):478-83
pubmed: 5457245
Curr Protoc Immunol. 2001 May;Chapter 3:Unit 3.19
pubmed: 18432783
Digestion. 2014;89(3):225-31
pubmed: 24861046
Nat Med. 2017 Jan;23(1):107-113
pubmed: 27892954
Science. 1996 Oct 11;274(5285):262-5
pubmed: 8824194
Gastroenterology. 2011 Oct;141(4):1314-22, 1322.e1-5
pubmed: 21745447
J Gastroenterol. 2011 Jul;46(7):894-905
pubmed: 21556830
Front Microbiol. 2016 Jun 28;7:979
pubmed: 27446020
Nat Rev Mol Cell Biol. 2003 Sep;4(9):721-32
pubmed: 14506475
PLoS One. 2017 Mar 27;12(3):e0173979
pubmed: 28346473
Gut. 2018 Aug;67(8):1445-1453
pubmed: 29269438
Gut. 2016 Mar;65(3):426-36
pubmed: 26100928
J Pharmacol Exp Ther. 2002 Dec;303(3):1248-54
pubmed: 12438549
Cell. 2008 Aug 8;134(3):392-404
pubmed: 18692464
PLoS One. 2017 Feb 24;12(2):e0173032
pubmed: 28235016
Clin Gastroenterol Hepatol. 2009 May;7(5):524-9
pubmed: 19249402
Curr Pharm Des. 2015;21(35):5089-93
pubmed: 26369683
J Gastroenterol. 2015 Apr;50(4):378-86
pubmed: 25501289
DNA Res. 2013 Jun;20(3):241-53
pubmed: 23571675
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Curr Med Chem. 2012;19(1):77-81
pubmed: 22300079
Gut. 2016 May;65(5):749-56
pubmed: 26719299
Nutrients. 2018 Oct 18;10(10):
pubmed: 30340338
Microbiome. 2014 Feb 24;2(1):6
pubmed: 24558975
PLoS One. 2015 Jul 02;10(7):e0132031
pubmed: 26135128
Gut. 2011 Aug;60(8):1050-9
pubmed: 21471573
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Circ J. 2013;77(7):1646-52
pubmed: 23803294
Gut. 2016 May;65(5):740-8
pubmed: 26657899
FEMS Microbiol Ecol. 2018 Nov 1;94(11):
pubmed: 30184128
Dig Dis Sci. 2018 Nov;63(11):2940-2949
pubmed: 29796911
Sci Rep. 2018 Aug 17;8(1):12384
pubmed: 30120330
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S15-22
pubmed: 20586859
BMJ. 2013 Jun 11;346:f3195
pubmed: 23757736
Am J Physiol Gastrointest Liver Physiol. 2013 Sep 1;305(5):G341-7
pubmed: 23832518
Cell. 2016 Nov 17;167(5):1339-1353.e21
pubmed: 27863247
Microb Pathog. 2017 May;106:171-181
pubmed: 26875998
Nature. 2011 Jan 27;469(7331):543-7
pubmed: 21270894
Nutrients. 2018 Sep 19;10(9):
pubmed: 30235828
PLoS One. 2013 Apr 30;8(4):e63099
pubmed: 23646181
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
pubmed: 16332807
Nutrients. 2011 Jan;3(1):104-17
pubmed: 22254077
Cell. 2016 Mar 24;165(1):111-124
pubmed: 26972052
Oncotarget. 2018 Jun 19;9(47):28638-28651
pubmed: 29983886
Int Rev Immunol. 2016 May 3;35(3):189-218
pubmed: 26606737
Biosci Microbiota Food Health. 2019;38(2):49-53
pubmed: 31106107
J Pharmacol Exp Ther. 2014 Jan;348(1):86-95
pubmed: 24135073
BMC Res Notes. 2014 Sep 04;7:605
pubmed: 25190469
J Neurogastroenterol Motil. 2018 Apr 30;24(2):182-196
pubmed: 29605975
Digestion. 2017;95(1):49-54
pubmed: 28052291
J Bone Miner Res. 1998 Aug;13(8):1290-9
pubmed: 9718198
Gut. 2008 Feb;57(2):181-7
pubmed: 17639086
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1469-1476
pubmed: 15388697
Appl Environ Microbiol. 2004 Dec;70(12):7220-8
pubmed: 15574920
World J Gastroenterol. 2014 Mar 28;20(12):3223-30
pubmed: 24696606
World J Gastroenterol. 2014 Nov 28;20(44):16452-63
pubmed: 25469013
Scand J Gastroenterol. 1995 Jan;30(1):25-32
pubmed: 7701246

Auteurs

Tsutomu Yoshihara (T)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Yosuke Oikawa (Y)

R&D Center, Biofermin Pharmaceutical Co., Ltd ., Kobe, Japan.

Takayuki Kato (T)

Department of Gastroenterology, International University of Health and Welfare Atami Hospital , Atami, Japan.

Takaomi Kessoku (T)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Takashi Kobayashi (T)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Shingo Kato (S)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Noboru Misawa (N)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Keiichi Ashikari (K)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Akiko Fuyuki (A)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Hidenori Ohkubo (H)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Takuma Higurashi (T)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Yoko Tateishi (Y)

Department of Pathology, Yokohama City University Hospital , Yokohama, Japan.

Yoshiki Tanaka (Y)

R&D Center, Biofermin Pharmaceutical Co., Ltd ., Kobe, Japan.

Shunji Nakajima (S)

R&D Center, Biofermin Pharmaceutical Co., Ltd ., Kobe, Japan.

Hiroshi Ohno (H)

R&D Center, Biofermin Pharmaceutical Co., Ltd ., Kobe, Japan.

Koichiro Wada (K)

Department of Pharmacology, Faculty of Medicine, Shimane University , Izumo, Japan.

Atsushi Nakajima (A)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine , Yokohama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH